ATLN

MKT CAP:$136M

Atlantic International Corp.

Market Cap

$136M

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$1.75-$0.29 (-13.97%)

Apr 23, 2026

Company Details

As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses o...

CEO

Jeffrey Jagid

IPO Date

Aug 27, 2021

Website

seqll.com

Key Metrics TTM

Revenue

$436M

-1.5% YoY

Net Income

-$59M

EPS (Diluted)

-$1.08

Free Cash Flow

-$4M

Revenue / Share

$7.95

Gross Margin

10.6%

Operating Margin

-11.5%

Net Margin

-13.6%

FCF Margin

-1.0%

P/S

0.3x

P/E

—

Earnings Reports

Q1 2026

May 12, 2026

PENDING

FY 2025

Apr 15, 2026

NEW

$436M-1.5%EPS -$1.08

Q4 2025

Apr 15, 2026

NEW

$120M-7.3%EPS -$0.48

Q3 2025

Nov 14, 2025

$110M+2.2%EPS -$0.20

Q2 2025

Aug 13, 2025

$103M-1.7%EPS -$0.20

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$50.9K	$25.3K	-$404.8K
Q4 21	$35.0K	$166	-$1M
Q2 22	$105M	$14M	$1M
Q3 22	$108M	$14M	$2M
Q4 22	$122M	$14M	$2M
Q2 23	$89M	$11M	-$1M
Q3 23	$98M	$12M	-$380.7K
Q4 23	$116M	$13M	-$2M
Q1 24	$101M	$10M	-$1M
Q2 24	$105M	$11M	-$8M
Q3 24	$108M	$12M	-$7M
Q4 24	$130M	$13M	-$6M
Q1 25	$103M	$11M	-$9M
Q2 25	$103M	$11M	-$9M
Q3 25	$110M	$12M	-$9M
Q4 25	$120M	$11M	-$23M

Valuation

Quarter	P/S	P/E
Q3 21	37362.3x	—
Q4 21	14639.5x	—
Q2 22	6.4x	—
Q3 22	2.7x	—
Q4 22	0.9x	—
Q2 23	1.0x	—
Q3 23	0.8x	—
Q4 23	0.2x	—
Q1 24	0.1x	—
Q2 24	0.6x	—
Q3 24	0.6x	—
Q4 24	0.6x	—
Q1 25	0.5x	—
Q2 25	0.2x	—
Q3 25	0.4x	—
Q4 25	0.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	-$841.6K	-$841.6K
Q4 21	-$966.9K	-$976.1K
Q2 22	-$4M	-$4M
Q3 22	$2M	$2M
Q4 22	-$5M	-$5M
Q2 23	$10M	$10M
Q3 23	-$7M	-$7M
Q4 23	-$12M	-$12M
Q1 24	$11M	$11M
Q2 24	-$15M	-$15M
Q3 24	-$1M	-$1M
Q4 24	-$426.3K	-$449.4K
Q1 25	$15M	$15M
Q2 25	-$10M	-$10M
Q3 25	-$1M	-$1M
Q4 25	-$8M	-$8M

Capital Expenditures

Quarter	CapEx
Q3 21	$3
Q4 21	$9.2K
Q2 22	$35.3K
Q3 22	$45.4K
Q4 22	$15.8K
Q2 23	$6.3K
Q3 23	$20.8K
Q4 23	$2.6K
Q1 24	$14.6K
Q2 24	$20.7K
Q3 24	$15.1K
Q4 24	$23.1K
Q1 25	$12.1K
Q2 25	$18.0K
Q3 25	$14.4K
Q4 25	$22.3K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	—	+291.9%
Q4 21	+299.6%	+1503.5%
Q2 22	+402444.6%	+25880.5%
Q3 22	+1802007.3%	+26074.0%
Q4 22	+239024.0%	+26243.8%
Q2 23	+255483.0%	+6329.2%
Q3 23	-6.9%	-5.2%
Q4 23	+7.8%	+11.9%
Q1 24	-17.3%	-15.2%
Q2 24	+17.1%	+24.8%
Q3 24	+10.2%	+16.5%
Q4 24	+11.5%	+14.2%
Q1 25	+2.2%	+10.3%
Q2 25	-1.7%	-1.2%
Q3 25	+2.2%	+4.0%
Q4 25	-7.3%	+5.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$214.7K	421.9%
Q4 21	$0	0.0%
Q2 22	$0	0.0%
Q3 22	$0	0.0%
Q4 22	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$5M	4.3%
Q3 24	$285.5K	0.3%
Q4 24	$40M	31.2%
Q1 25	$6M	5.9%
Q2 25	$6M	6.1%
Q3 25	$7M	6.1%
Q4 25	$17M	14.3%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q3 21	$90.7K	—	—	$339.4K
Q4 21	$397.0K	—	—	$975.4K
Q2 22	—	—	—	$11M
Q3 22	—	—	—	$10M
Q4 22	—	$10M	$859.5K	—
Q2 23	—	—	—	$11M
Q3 23	—	—	—	$10M
Q4 23	—	$15M	$962.6K	—
Q1 24	—	—	—	$10M
Q2 24	—	—	—	$19M
Q3 24	—	—	—	$17M
Q4 24	—	—	—	$18M
Q1 25	—	—	—	$19M
Q2 25	—	—	—	$19M
Q3 25	—	—	—	$20M
Q4 25	—	—	—	$33M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$9M	$0	$9M
Q2 22	$8M	$0	$8M
Q3 22	$4M	$2M	$7M
Q4 22	$2M	$4M	$6M
Q1 23	$5M	$2M	$7M
Q2 23	$5M	$0	$5M
Q3 23	$4M	$0	$4M
Q4 23	$3M	$0	$3M
Q1 24	$2M	$0	$2M
Q2 24	$439.5K	$0	$439.5K
Q3 24	$1M	$0	$1M
Q4 24	$678.7K	$0	$678.7K
Q1 25	$1M	$0	$1M
Q2 25	$374.7K	$0	$374.7K
Q3 25	$83.4K	$0	$83.4K
Q4 25	$81.1K	$0	$81.1K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	22M	+8.5%	+1.6%
Q4 21	22M	0.0%	+1.6%
Q2 22	22M	0.0%	+1.6%
Q3 22	22M	0.0%	+8.5%
Q4 22	22M	0.0%	0.0%
Q2 23	25M	+16.8%	+16.8%
Q3 23	25M	+0.3%	+17.2%
Q4 23	25M	0.0%	+17.2%
Q1 24	25M	0.0%	+17.2%
Q2 24	28M	+10.5%	+10.8%
Q3 24	45M	+59.1%	+75.8%
Q4 24	53M	+18.9%	+109.0%
Q1 25	54M	+1.6%	+112.3%
Q2 25	55M	+1.1%	+94.3%
Q3 25	55M	0.0%	+22.1%
Q4 25	55M	+0.5%	+3.2%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	—	—
Q4 21	$5.0K	7
Q2 22	$15M	7
Q3 22	$15M	7
Q4 22	$17M	7
Q2 23	$13M	7
Q3 23	$14M	7
Q4 23	$17M	7
Q1 24	$14M	7
Q2 24	$15M	7
Q3 24	$15M	7
Q4 24	$431.8K	300
Q1 25	$342.7K	300
Q2 25	$343.0K	300
Q3 25	$367.1K	300
Q4 25	$382.3K	314

Revenue / Employee